Hematopoietic JAK2^V617F-mediated clonal hematopoiesis: AIM2 understand mechanisms of atherogenesis

References

[1] Jaiswal S,Silver AJ.Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease.N Engl J Med2017;377:111-21 PMCID:PMC6717509

[2] Wolach O,Martinod K.Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms.Sci Transl Med2018;10:eaan8292 PMCID:PMC6442466

[3] Cordua S,Skov V.Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population.Blood2019;134:469-79

[4] Wang W,Fidler T.Macrophage inflammation, erythrophagocytosis, and accelerated atherosclerosis in Jak2 (V617F) mice.Circ Res2018;123:e35-47 PMCID:PMC6309796

[5] Sano S,Yura Y.JAK2 (V617F)-mediated clonal hematopoiesis accelerates pathological remodeling in murine heart failure.JACC Basic Transl Sci2019;4:684-97 PMCID:PMC6834960

[6] Fidler TP,Yalcinkaya M.The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis.Nature2021;592:296-301 PMCID:PMC8038646

[7] Silvestre-Roig C,Wichapong K.Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death.Nature2019;569:236-40 PMCID:PMC6716525

[8] Fuster JJ,Zuriaga MA.Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.Science2017;355:842-7 PMCID:PMC5542057

[9] Sano S,Wang Y.Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1beta/NLRP3 inflammasome.J Am Coll Cardiol2018;71:875-86 PMCID:PMC5828038